Erythromycin 4%/Tretinoin 0.025% Topical Gel is a compounded medication, dispensed via a pump for easy, precise application. This semisolid, gel-like formulation is intended for targeted treatment of various skin conditions such as Acne Vulgaris, Rosacea, Seborrheic Dermatitis, Melasma, and Actinic Keratosis.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Erythromycin 4%/Tretinoin 0.025% Topical Gel is a compounded formulation designed to treat various skin conditions. This dual-action medication combines the potent effects of erythromycin, an antibiotic, and tretinoin, a retinoid. These two active ingredients work synergistically to combat inflammation, reduce bacteria, and promote the healing process.
Erythromycin functions by eliminating bacteria that can lead to skin infections, while tretinoin aids in reducing inflammation and promoting skin cell turnover. This combination results in a powerful treatment that can effectively manage acne, rosacea, and other inflammatory skin conditions.
This topical gel is dispensed in a semisolid formulation through a pump mechanism, which allows for easy and precise application. The gel-like consistency ensures targeted treatment and optimal absorption of the active ingredients into the skin. It is crucial to follow the directions provided on the package and to use the medication as directed by your healthcare provider for the best results.
Erythromycin 4%/Tretinoin 0.025% Topical Gel is a appropriate treatment option for various skin conditions. However, if you have any questions or concerns about this medication or any other, please do not hesitate to contact us at Bayview Pharmacy. Our team of experienced compounding pharmacists is here to assist you in finding the most suitable treatment for your skin condition.
Erythromycin 4%/Tretinoin 0.025% Topical Gel is a compounded formulation specifically designed for the treatment of acne vulgaris. This semisolid formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin. The gel-like consistency ensures targeted treatment or absorption of the active ingredients, Erythromycin and Tretinoin, directly into the affected area.
It is crucial to understand that this formulation should not be used concurrently with other topical acne medications. Doing so may increase the risk of skin irritation or other adverse reactions. Similarly, the use of other topical medications in conjunction with this formulation is not recommended, as it may heighten the risk of skin irritation or other adverse effects.
Patients are strongly advised to avoid exposure to sunlight or artificial UV light while using this medication. Such exposure may increase the risk of skin irritation or other adverse reactions. Furthermore, patients should refrain from using other topical products on the same area of skin as this medication, as this may also increase the risk of skin irritation or other adverse reactions.
If you have any questions or concerns regarding the use of Erythromycin 4%/Tretinoin 0.025% Topical Gel, please do not hesitate to reach out for further clarification. Your safety and well-being are our utmost priority.
Erythromycin 4%/Tretinoin 0.025% Topical Gel is a compounded formulation designed to combat acne. This dual-action medication combines the potent effects of Erythromycin, an antibiotic that halts bacterial growth, and Tretinoin, a derivative of vitamin A that aids in reducing the production of sebum, an oily substance that can block pores and contribute to acne. Together, these two active ingredients work synergistically to reduce inflammation, eliminate bacteria, and decrease sebum production, thereby helping to clear up acne.
This topical gel is dispensed through a pump mechanism, which allows for easy and precise application on the skin. This targeted treatment ensures that the active ingredients are delivered directly to the affected area, enhancing their efficacy. It is crucial to follow the instructions provided by your healthcare provider when using this medication. Typically, the gel should be applied to the affected area once or twice daily, as directed. Care should be taken to avoid contact with the eyes, nose, or mouth, and concurrent use of other topical medications on the same skin area should be avoided as it may increase the risk of side effects.
Common side effects of Erythromycin 4%/Tretinoin 0.025% Topical Gel may include skin dryness, redness, itching, burning, and peeling. If these side effects persist or become severe, it is recommended to contact your healthcare provider.
If you have any questions or concerns about using Erythromycin 4%/Tretinoin 0.025% Topical Gel, please do not hesitate to reach out to your healthcare provider or pharmacist. They are there to assist you in your treatment journey and ensure that you are using this medication safely and effectively.
This compounded formulation of Erythromycin 4%/Tretinoin 0.025% Topical Gel is a semisolid preparation that is dispensed through a pump mechanism. This design allows for easy and precise application on the skin, ensuring targeted treatment or absorption of the active ingredients. The gel-like consistency of the formulation enhances its spreadability on the skin.
These include Acne Vulgaris, Rosacea, Seborrheic Dermatitis, Melasma, and Actinic Keratosis. It is also beneficial in treating other skin conditions such as folliculitis, perioral dermatitis, and post-inflammatory hyperpigmentation.
Aside from treating skin conditions, this formulation also offers cosmetic benefits. This makes it a versatile product that addresses both medical and aesthetic skin concerns.
As with any topical medication, it is crucial to follow the instructions of your healthcare provider and use the medication as directed. If you have any questions or concerns about the use of this formulation, it is recommended to consult with your healthcare provider or a qualified professional.
This is a compounded formulation that combines Erythromycin, an antibiotic, and Tretinoin, a form of vitamin A. It is used to treat certain types of acne and promote skin renewal.
This formulation is dispensed through a pump mechanism, which allows for easy and precise application on the skin.
The Erythromycin 4%/Tretinoin 0.025% Topical Gel has a gel-like consistency, which allows it to be easily spread on the skin for targeted treatment.
Apply a thin layer of the gel to the affected area of the skin as directed by your healthcare provider. Avoid contact with the eyes, mouth, and other mucous membranes.
If you miss a dose, apply it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Common side effects may include skin dryness, burning, redness, excessive flaking, or peeling. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Before using other skincare products, consult with your healthcare provider. Some products may interfere with the effectiveness of the Erythromycin 4%/Tretinoin 0.025% Topical Gel.
Store this medication at room temperature, away from heat and direct light. Do not freeze. Keep the container tightly closed when not in use.
Consult your healthcare provider before using this medication if you are pregnant or breastfeeding. Tretinoin may be absorbed through the skin and could harm an unborn baby.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services. Otherwise, call a poison control center right away.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)